Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/A1SN34 stock hub

BVMF/A1SN34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/A1SN34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

72.6B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/A1SN34

In the news

Latest news · BVMF/A1SN34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.9

P25 11.3P50 14.6P75 19.6

Trailing P/E24.3

P25 15.2P50 21.5P75 27.3

ROE332.7

P25 5.3P50 12.3P75 22.5

ROIC-0.9

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/A1SN34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

EUR

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	BR
Employees	1,189
Employees Change	172%
Employees Change Percent	16.91
Enterprise value	BRL 74.4B
Exchange	Brazil Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	BRL 72.6B
Price	BRL 76.05
Price currency	BRL
Rev Per Employee	4,379,795.07x
Sector	Healthcare
Sic	2836
Symbol	bvmf/A1SN34
Website	https://ascendispharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.11%
EV Earnings	24.95x
EV/FCF	275.01x
EV/Sales	17.97x
FCF yield	0.37%
Forward P/E	18.93x
P/B ratio	24.73x
P/E ratio	24.34x
P/S ratio	13.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.7%
EBITDA Margin	-1.18%
FCF margin	5.2%
Gross margin	89.04%
Gross Profit	BRL 4.6B
Gross Profit Growth	145.11%
Gross Profit Growth Q	174.56%
Gross Profit Growth3 Y	127.55%
Gross Profit Growth5 Y	65.02%
Net Income	BRL 3B
Pretax Margin	-19.32%
Profit Margin	57.28%
Profit Per Employee	BRL 2.5M
ROA	-0.6
Roa5y	-22.72
ROCE	-1.68
ROE	332.7
ROIC	-0.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	35.59%
Cagr3y	26.01%
Revenue Growth	134.82x
Revenue Growth Q	144.27x
Revenue Growth3 Y	123.13x
Revenue Growth5 Y	175.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.57
Assets	BRL 12B
Cash	BRL 3.4B
Current Assets	BRL 6.5B
Current Liabilities	BRL 6.5B
Debt	BRL 5.4B
Debt EBITDA	BRL 422
Debt Equity	BRL 1.84
Debt FCF	BRL 19.93
Equity	BRL 2.9B
Interest Coverage	-0.13
Liabilities	BRL 9.1B
Long Term Assets	BRL 5.5B
Long Term Liabilities	BRL 2.6B
Net Cash	BRL -1.9B
Net Cash By Market Cap	BRL -2.68
Net Debt Equity	BRL 0.66
Net Debt FCF	BRL 7.2
Tangible Book Value	BRL 2.9B
Tangible Book Value Per Share	BRL 46.9
WACC	7.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1
Inventory Turnover	0.31
Net Working Capital	BRL -401.1M
Quick ratio	0.68
Working Capital	BRL -26.6M
Working Capital Turnover	BRL 330

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	35.56%
3Y total return	100.13%
50-day SMA	66.22
All Time High	78.57
All Time High Change	-3.21%
All Time High Date	2026-03-20
All Time Low	22.32
All Time Low Change	240.73%
All Time Low Date	2023-04-03
ATR	2.67
Beta	0.49
Ch YTD	-1.23
High	76.05
High52	78.57
High52 Date	2026-03-20
High52ch	-3.21%
Low	76.05
Low52	53.79
Low52 Date	2025-04-07
Low52ch	41.38%
Ma50ch	14.84%
RSI	57.32
RSI Monthly	70.45
RSI Weekly	74.25
Sharpe ratio	1.65x
Sortino ratio	2.56
Total Return	-5.21%
Tr YTD	-1.23
Tr1m	-0.25%
Tr1w	-3.21%
Tr3m	1.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL -88.7M
Operating margin	-1.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	61,779,750%
Net Borrowing	-159,208,670.2
Shares Institutions	26.21%
Shares Qo Q	5.74%
Shares Yo Y	5.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL -457M
Average Volume	261.5x
Bv Per Share	47.26
CAPEX	BRL -93.2M
Ch1m	-0.25
Ch1w	-3.21
Ch1y	35.56
Ch3m	1.4
Ch3y	100.1
Ch6m	9.74
Change	-3.21%
Change From Open	0
Close	78.57
Days Gap	-3.21
Depreciation Amortization	26,258,535.4
Dollar Volume	3,802.5
Earnings Date	2026-05-07
EBIT	BRL -88.7M
EBITDA	BRL -61.5M
EPS	BRL 48.33
F Score	5
FCF	BRL 270.6M
FCF EV Yield	0.36x
Financing CF	105,375,078
Fiscal Year End	December
Founded	2,006
Graham Number	14.70253
Graham Upside	-80.67
Income Tax	BRL -4B
Investing CF	-87,426,609
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	49.97
Ma150ch	52.18%
Ma20	72.84
Ma20ch	4.41%
Net CF	330,200,106
Next Earnings Date	2026-09-04
Open	76.05
P FCF Ratio	268.3
P OCF Ratio	199.5
Ppne	787,686,518.5
Price Date	2026-03-24
Ptbv Ratio	24.92
Relative Volume	0.19x
Revenue	5,207,576,333x
SBC By Revenue	13.97x
Share Based Comp	727,616,749
Tax By Revenue	-76.6x
Tr6m	9.74%
Volume	50
Z Score	-1.05

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/A1SN34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/A1SN34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/A1SN34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.2%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.2%

Negative means the company is buying back shares.

Technical

BVMF/A1SN34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.3

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

1.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/A1SN34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/A1SN34 stock rating?

bvmf/A1SN34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/A1SN34 analysis?

The full report lives at /stocks/bvmf/A1SN34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/A1SN34?

The latest report frames bvmf/A1SN34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/A1SN34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.